Primo Brands Corporation Class A PRMB 深滬

等待開盤 02-10 09:30:00 美东时间

18.88

-0.750

-3.82%

華盛通

立即下載

最高19.755
今開19.65
成交量 542.91万股
最低 18.86
昨收 19.63
總市值 69.03亿
52周最高 35.545
市盈率 ^靜 --
換手率 1.48%
52周最低 14.26
委比 68.67%
總股本 3.66亿
歷史最高 35.545
量比 1.05
振幅 4.56%
歷史最低 14.26
每手 1
風險率 6.27%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元

01-09 20:22
美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级；瑞银下调甲骨文目标价从325美元至280美元

今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元

01-06 17:52
Morgan Stanley Maintains Overweight on Primo Brands, Lowers Price Target to $26

Morgan Stanley analyst Eric Serotta maintains Primo Brands (NYSE:PRMB) with a Overweight and lowers the price target from $28 to $26.

01-06 02:05
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级

今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元

2025-12-19 10:15
JP Morgan Maintains Overweight on Primo Brands, Lowers Price Target to $21

JP Morgan analyst Andrea Teixeira maintains Primo Brands (NYSE:PRMB) with a Overweight and lowers the price target from $23 to $21.

2025-12-19 00:54
Primo Brands Files Prospectus For Resale Of 116M Shares And Issuance Of 58,488 Option Shares

Resale of up to 116,210,806 Shares of Class A Common StockIssuance of up to 58,488 shares of Class A Common Stock underlying Options This prospectus relates to the (i) resale or other disposition of

2025-12-06 05:40
美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元

今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元

2025-11-26 10:07
Goldman Sachs Maintains Neutral on Primo Brands, Lowers Price Target to $18

Goldman Sachs analyst Bonnie Herzog maintains Primo Brands (NYSE:PRMB) with a Neutral and lowers the price target from $21 to $18.

2025-11-26 01:45
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价

今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元

2025-11-11 10:49
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元

2025-11-10 17:17

派息除權日	每股總股息	派息日期
2025-11-25	0.10	2025-12-05
2025-08-21	0.10	2025-09-04
2025-06-06	0.10	2025-06-17
2025-03-07	0.10	2025-03-24
2024-11-22	0.09	2024-12-05
2024-11-05	0.82	2024-11-21
2024-08-22	0.09	2024-09-05
2024-06-07	0.09	2024-06-18
2024-03-07	0.09	2024-03-25
2023-11-20	0.08	2023-12-01
2023-08-23	0.08	2023-09-07
2023-06-01	0.08	2023-06-14
2023-03-09	0.08	2023-03-27
2022-11-28	0.07	2022-12-09
2022-08-23	0.07	2022-09-07
2022-06-09	0.07	2022-06-22
2022-03-10	0.07	2022-03-28
2021-11-22	0.06	2021-12-03
2021-08-18	0.06	2021-09-02
2021-06-03	0.06	2021-06-16
2021-03-11	0.06	2021-03-29
2020-11-23	0.06	2020-12-04
2020-08-18	0.06	2020-09-02
2020-06-04	0.06	2020-06-17
2020-03-09	0.06	2020-03-25
2019-11-25	0.06	2019-12-06
2019-08-20	0.06	2019-09-04
2019-05-30	0.06	2019-06-12
2019-03-11	0.06	2019-03-27
2018-11-26	0.06	2018-12-07
2018-08-21	0.06	2018-09-05
2018-05-31	0.06	2018-06-13
2018-03-12	0.06	2018-03-28
2017-11-27	0.06	2017-12-08
2017-08-21	0.06	2017-09-06
2017-05-31	0.06	2017-06-14
2017-03-10	0.06	2017-03-29
2016-11-23	0.06	2016-12-08
2016-08-23	0.06	2016-09-07
2016-06-01	0.06	2016-06-15
2016-03-07	0.06	2016-03-24
2015-11-27	0.06	2015-12-10
2015-08-25	0.06	2015-09-09
2015-06-03	0.06	2015-06-17
2015-03-09	0.06	2015-03-27
2014-11-26	0.06	2014-12-11
2014-08-26	0.06	2014-09-10
2014-06-04	0.06	2014-06-18
2014-03-07	0.05	2014-03-28
2013-11-27	0.06	2013-12-12
1998-06-22	0.02	1998-06-30
1998-04-17	0.02	1998-04-24
1997-12-15	0.02	1997-12-24
1997-09-17	0.02	1997-09-26
1997-06-30	0.02	1997-07-04
1996-02-15	0.02	1996-02-29
1995-11-17	0.02	1995-11-30
1995-08-18	0.02	1995-08-31
1995-05-16	0.02	1995-05-31
1995-02-13	0.02	1995-02-28
1994-11-14	0.02	1994-11-30
1994-08-15	0.02	1994-08-30
1994-05-16	0.01	1994-05-30
1994-02-14	0.01	1994-02-28
1993-11-10	0.02	1993-11-26
1993-08-09	0.02	1993-08-27
1993-05-17	0.02	1993-05-27
1993-02-12	0.02	1993-02-25
1992-11-03	0.02	1992-11-23
1992-08-10	0.02	1992-08-21

公司名稱	Primo Water Corp.
行業分類	Beverages: Non-Alcoholic
業務描述	Primo Brands Corp. is a branded beverage company, which focuses on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points and consumer occasions, distributed in the United States and Canada. The company provides water filtration units for home and business consumers across North America. It also offers reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and innovative brand packaging portfolio, which includes recycled plastic, aluminum and glass. Primo Brands was founded in 2024 and is headquartered in Tampa, FL.

Primo Brands Corporation Class A PRMB 深 滬

18.88

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Primo Brands Corporation Class A PRMB 深滬